Revolution Medicines Inc. (RVMD)
NASDAQ
Closed
Aug 24, 2026
Day's Range
205.3952 wk Range
35.62Overview - RVMD - Revolution Medicines Inc.
Key Statistics
Valuation
Enterprise Value
42.14B
P/E (Trailing)
‪-35.55‬
P/E (Forward)
‪-31.46‬
PEG Ratio
‪-0.26‬
Price / Book
‪27.95‬
EV / EBITDA
‪-26.04‬
Profitability
Profit Margin
‪0.00%‬
Operating Margin
‪0.00%‬
Return on Assets
‪-30.12%‬
Return on Equity
‪-79.08%‬
Ownership
Shares Outstanding
214.24M
Float
184.45M
Short % of Shares Outstanding
‪5.67%‬
Held by Insiders
‪1.87%‬
Held by Institutions
‪100.99%‬
Price stats
Beta
‪1.40‬
50-Day Avg
‪187.00‬
200-Day Avg
‪126.66‬
Dividends
Payout Ratio
‪0.00%‬
Shariah Compliance
Report Date: Feb 19, 2025
Screened by Zoya using the AAOIFI methodology.
Peers - RVMD - Revolution Medicines Inc.
Peer Comparison
Compared with companies in Biotechnology listed on NASDAQ.
- RVMDNASDAQRevolution Medicines Inc.41.12BMarket Cap+81.34%52-week change-33.01P/E (Trailing)‪0.00%‬Profit Margin
- ARGXNASDAQargenx SE American Depositary Receipt62.93BMarket Cap+33.08%52-week change39.69P/E (Trailing)‪32.26%‬Profit Margin
- ALNYNASDAQAlnylam Pharmaceuticals Inc31.58BMarket Cap-87.93%52-week change40.23P/E (Trailing)‪16.12%‬Profit Margin
- BNTXNASDAQBioNTech SE28.34BMarket Cap+7.12%52-week change160.80P/E (Trailing)‪-63.63%‬Profit Margin
- ASNDNASDAQAscendis Pharma A/S16.61BMarket Cap+23.98%52-week change19.38P/E (Trailing)‪70.84%‬Profit Margin
- BBIONASDAQBridgeBio Pharma, Inc.15.84BMarket Cap+39.72%52-week change-21.44P/E (Trailing)‪-97.02%‬Profit Margin
- BMRNNASDAQBiomarin Pharmaceutical Inc.12.59BMarket Cap+11.71%52-week change180.27P/E (Trailing)‪2.14%‬Profit Margin
Profile Summary - RVMD - Revolution Medicines Inc.
About
Revolution Medicines Inc. is a clinical-stage precision oncology company focused on developing targeted cancer therapies. The company concentrates on inhibiting difficult-to-drug molecular targets within key cell growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways that are…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
